|
EP4048664A1
(en)
|
2019-10-25 |
2022-08-31 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
ES3016132T3
(en)
|
2020-01-29 |
2025-05-08 |
Gilead Sciences Inc |
Glp-1r modulating compounds
|
|
TW202206429A
(zh)
|
2020-04-29 |
2022-02-16 |
美商迦舒布魯姆生物有限公司 |
雜環ｇｌｐ—１促效劑
|
|
JP2023537501A
(ja)
|
2020-08-06 |
2023-09-01 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
EP4204415A4
(en)
|
2020-08-28 |
2025-03-26 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
CA3188891A1
(en)
|
2020-09-01 |
2022-01-13 |
Fanglong Yang |
Fused imidazole derivative, preparation method therefor, and medical use thereof
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
CR20230330A
(es)
*
|
2021-01-28 |
2023-11-15 |
Carmot Therapeutics Inc |
Agonistas del receptor gpcr, composiciones farmaceuticas que los comprenden y métodos para su uso
|
|
WO2022184849A1
(en)
*
|
2021-03-04 |
2022-09-09 |
Les Laboratoires Servier |
Glp-1r agonists, uses and pharmaceutical compositions thereof
|
|
WO2022192428A1
(en)
*
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
EP4304712A1
(en)
*
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
US20240208952A1
(en)
*
|
2021-03-22 |
2024-06-27 |
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. |
Thiophene glp-1 receptor agonist and use thereof
|
|
JP7772778B2
(ja)
*
|
2021-03-24 |
2025-11-18 |
塩野義製薬株式会社 |
縮合環を有するｇｌｐ－１受容体作動薬を含有する医薬組成物
|
|
CN117222631A
(zh)
*
|
2021-03-24 |
2023-12-12 |
诚益生物(美国)公司 |
苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-苯基-、苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-杂芳基-或苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-哌啶基-甲基-氧杂环丁烷基甲基-1h-苯并[d]咪唑-甲酸衍生物及其使用方法
|
|
IL306110A
(en)
|
2021-04-21 |
2023-11-01 |
Gilead Sciences Inc |
Carboxy-benzimidazole glp-1r modulating compounds
|
|
TWI843104B
(zh)
|
2021-05-20 |
2024-05-21 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2023011539A1
(zh)
*
|
2021-08-04 |
2023-02-09 |
上海翰森生物医药科技有限公司 |
环烯类衍生物调节剂、其制备方法和应用
|
|
US20240374587A1
(en)
|
2021-09-08 |
2024-11-14 |
Shionogi & Co., Ltd. |
Medicine for prevention and treatment of diseases linked to anti-obesity activity
|
|
PT4408840T
(pt)
|
2021-09-27 |
2025-10-07 |
Terns Pharmaceuticals Inc |
Ácidos benzimidazolocarboxílicos como agonistas de glp-1r
|
|
US20250115612A1
(en)
|
2021-10-05 |
2025-04-10 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4-b]pyrazines as glp-1 receptor modulators
|
|
WO2023057414A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
MX2024004131A
(es)
|
2021-10-05 |
2024-04-22 |
Astrazeneca Ab |
Ciertos 2,5-diazabiciclo[4.2.0]octanos como moduladores del receptor de glp-1.
|
|
CN118401519A
(zh)
|
2021-10-25 |
2024-07-26 |
拓臻制药公司 |
作为glp-1r激动剂的化合物
|
|
US20250042882A1
(en)
|
2021-12-16 |
2025-02-06 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
WO2023111144A1
(en)
|
2021-12-16 |
2023-06-22 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
CN119095843A
(zh)
|
2022-02-23 |
2024-12-06 |
拓臻制药公司 |
作为glp-1r激动剂的化合物
|
|
US20250214968A1
(en)
*
|
2022-03-25 |
2025-07-03 |
Ildong Pharmaceutical Co., Ltd. |
Novel Salt of GLP-1 Receptor Agonist Compound, Preparation Method Thereof and Pharmaceutical Composition Comprising Thereof
|
|
US20250136584A1
(en)
*
|
2022-05-20 |
2025-05-01 |
Chengdu Di'ao Jiuhong Pharmaceutical Factory |
Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof
|
|
CN120289354A
(zh)
*
|
2022-07-18 |
2025-07-11 |
厦门市博瑞来医药科技有限公司 |
五元并六元化合物、其中间体、制备方法、组合物和应用
|
|
JPWO2024063140A1
(cg-RX-API-DMAC7.html)
*
|
2022-09-22 |
2024-03-28 |
|
|
|
EP4592285A1
(en)
|
2022-09-22 |
2025-07-30 |
Shionogi & Co., Ltd. |
Fused ring compound having glp-1 receptor agonist effect
|
|
CN116102543B
(zh)
*
|
2022-10-21 |
2025-07-22 |
江南大学 |
一种glp-1r激动剂、合成方法及其用途
|
|
WO2024102625A1
(en)
|
2022-11-11 |
2024-05-16 |
Eli Lilly And Company |
Glucagon-like peptide 1 receptor agonists
|
|
KR20250085816A
(ko)
|
2022-11-16 |
2025-06-12 |
일라이 릴리 앤드 캄파니 |
글루카곤-유사 펩티드 1 수용체 효능제
|
|
TW202434574A
(zh)
*
|
2023-02-02 |
2024-09-01 |
大陸商江蘇豪森藥業集團有限公司 |
一種環烯類化合物的鹽、晶型及其製備方法和應用
|
|
EP4568664B1
(en)
|
2023-04-07 |
2026-04-01 |
Terns Pharmaceuticals, Inc. |
Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity
|
|
WO2024212742A1
(zh)
*
|
2023-04-10 |
2024-10-17 |
上海研健新药研发有限公司 |
一种glp-1r激动剂，其制备方法和应用
|
|
CN120981457A
(zh)
|
2023-09-14 |
2025-11-18 |
歌礼制药(中国)有限公司 |
Glp-1r激动剂及其治疗方法
|
|
TW202515865A
(zh)
*
|
2023-09-21 |
2025-04-16 |
南韓商尹諾衛醫藥有限公司 |
製備取代的稠合咪唑衍生物的方法
|
|
TW202521534A
(zh)
|
2023-11-24 |
2025-06-01 |
香港商歌禮製藥(中國)有限公司 |
Glp-1r 激動劑及其治療方法
|
|
TW202600132A
(zh)
|
2024-03-08 |
2026-01-01 |
美商安尼波那生物公司 |
用於治療肥胖症及提高減重之方法
|